Tobam United Therapeutics Corp Transaction History

Tobam

$256 Million
Q2 2025

A detailed history of Tobam transactions in United Therapeutics Corp stock. As of the latest transaction made, Tobam holds 2,693 shares of UTHR stock, worth $811,939. This represents 0.3% of its overall portfolio holdings.

Number of Shares

2,693

Previous 6,388 57.84%

Holding current value

$811,939

Previous $1.97 Million 60.69%

% of portfolio

0.3%

Previous 0.84%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$276.47 - $328.4 $1.02 Million - $1.21 Million	-3,695 Reduced 57.84%	2,693 $774,000
Q1 2025 Apr 16, 2025	SELL	$304.42 - $380.78 $3.6 Million - $4.51 Million	-11,834 Reduced 64.94%	6,388 $1.97 Million
Q4 2024 Jan 28, 2025	SELL	$348.66 - $410.0 $6.88 Million - $8.08 Million	-19,719 Reduced 51.97%	18,222 $6.43 Million
Q3 2024 Oct 09, 2024	SELL	$311.04 - $363.55 $5.7 Million - $6.66 Million	-18,317 Reduced 32.56%	37,941 $13.6 Million
Q2 2024 Jul 29, 2024	SELL	$228.26 - $319.04 $12 Million - $16.7 Million	-52,389 Reduced 48.22%	56,258 $17.9 Million
Q1 2024 May 02, 2024	SELL	$210.76 - $249.51 $1.08 Million - $1.27 Million	-5,110 Reduced 4.49%	108,647 $25 Million
Q4 2023 Jan 26, 2024	SELL	$214.88 - $256.94 $6.8 Million - $8.14 Million	-31,663 Reduced 21.77%	113,757 $25 Million
Q3 2023 Oct 31, 2023	SELL	$211.82 - $248.24 $650,922 - $762,841	-3,073 Reduced 2.07%	145,420 $32.8 Million
Q2 2023 Jul 31, 2023	SELL	$205.19 - $232.99 $4.4 Million - $4.99 Million	-21,430 Reduced 12.61%	148,493 $32.8 Million
Q1 2023 May 03, 2023	BUY	$212.99 - $276.17 $12.9 Million - $16.7 Million	60,639 Added 55.49%	169,923 $38.1 Million
Q4 2022 Feb 02, 2023	BUY	$205.95 - $280.43 $14 Million - $19 Million	67,767 Added 163.23%	109,284 $30.4 Million
Q3 2022 Nov 02, 2022	BUY	$203.3 - $244.17 $7.67 Million - $9.22 Million	37,750 Added 1002.12%	41,517 $8.69 Million
Q2 2022 Aug 02, 2022	BUY	$174.81 - $241.14 $658,509 - $908,374	3,767 New	3,767 $888,000
Q1 2019 May 15, 2019	SELL	$107.15 - $126.84 $1.83 Million - $2.17 Million	-17,080 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$101.4 - $128.73 $1.92 Million - $2.43 Million	-18,915 Reduced 52.55%	17,080 $1.86 Million
Q3 2018 Nov 08, 2018	SELL	$113.81 - $129.46 $928,348 - $1.06 Million	-8,157 Reduced 18.47%	35,995 $4.6 Million
Q2 2018 Aug 03, 2018	BUY	$101.14 - $118.31 $897,516 - $1.05 Million	8,874 Added 25.15%	44,152 $5 Million
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $325,382 - $461,137	3,035 Added 9.41%	35,278 $3.96 Million
Q4 2017 Feb 14, 2018	SELL	$118.58 - $151.28 $4.17 Million - $5.32 Million	-35,156 Reduced 52.16%	32,243 $4.77 Million
Q3 2017 Nov 14, 2017	SELL	$114.6 - $136.81 $40,797 - $48,704	-356 Reduced 0.53%	67,399 $7.9 Million
Q2 2017 Aug 08, 2017	BUY	N/A	67,755	67,755 $8.79 Million

Others Institutions Holding UTHR

# of Institutions

730

Shares Held

43.3M

Call Options Held

125K

Put Options Held

124K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $13.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tobam, based on Form 13F filings with the SEC.

News

Stay updated on Tobam with notifications on news.

Account